Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Natalia N. Shestakova"'
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
N-methyl-D-aspartate receptors (NMDARs) are an essential target for the analgetic action of tricyclic antidepressants (TCAs). Their therapeutic blood concentrations achieve 0.5–1.5 μM, which, however, are insufficient to cause in vitro the open-ch
Externí odkaz:
https://doaj.org/article/7b363b8ad4da4ed4a0729c6f475c0349
Autor:
Daria A. Belinskaia, Mariia A. Belinskaia, Oleg I. Barygin, Nina P. Vanchakova, Natalia N. Shestakova
Publikováno v:
Pharmaceuticals, Vol 12, Iss 2, p 99 (2019)
Clinical observations have shown that patients with chronic neuropathic pain or itch exhibit symptoms of increased anxiety, depression and cognitive impairment. Such patients need corrective therapy with antidepressants, antipsychotics or anticonvuls
Externí odkaz:
https://doaj.org/article/674ecd84b79d424cb876559961bb53fd
Autor:
Rajnish Kumar, Natalia N. Shestakova, Daria A. Belinskaia, Shivani Vaidya, Vinod Tiwari, Ankit Uniyal, Sanjay Singh, P. A. Shantanu
Publikováno v:
ACS Chemical Neuroscience. 12:1948-1960
Kinesins are the motor proteins that transport excitatory receptors to the synaptic membrane by forming a complex with receptor cargo leading to central sensitization causing neuropathic pain. Many regulatory proteins govern the transit of receptors
Publikováno v:
Journal of Evolutionary Biochemistry and Physiology. 57:694-703
Tricyclic antidepressants, specifically amitriptyline (ATL) and desipramine (DES) are currently used to treat depression and chronic pain of various origins, in which NMDA receptor dysfunctions play an important role. The effect of therapeutic ATL co
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
N-methyl-D-aspartate receptors (NMDARs) are an essential target for the analgetic action of tricyclic antidepressants (TCAs). Their therapeutic blood concentrations achieve 0.5–1.5 μM, which, however, are insufficient to cause in vitro the open-ch
Autor:
Sneha Shaw, Pran Kishore Deb, Vinod K. Tiwari, Ankit Uniyal, Daria A. Belinskaia, Anagha Gadepalli, Katharigatta N. Venugopala, Vineeta Tiwari, Natalia N. Shestakova
Publikováno v:
European journal of pharmacology. 889
Neuropathic pain is a critical burdensome problem due to the complex interplay of several pathological mechanisms and lack of availability of effective therapeutic interventions. The available therapeutic options are associated with a variety of limi
Autor:
Elina I. Nagaeva, Nina P. Vanchakova, Oleg I. Barygin, Darya A. Belinskaya, Natalia N. Shestakova, Denis B. Tikhonov
Publikováno v:
Brain Research. 1660:58-66
It is known that some antidepressants and antipsychotics directly inhibit NMDA-type ionotropic glutamate receptors. In this study we systematically studied action of seven drugs (Fluoxetine, Citalopram, Desipramine, Amitriptyline, Atomoxetine, Chlorp
Autor:
Natalia N. Shestakova, Sergei I. Boikov, P. A. Abushik, Daria A. Belinskaia, Yulia D. Stepanenko, D. A. Sibarov, Nina Pavlovna Vanchakova, Sergei M. Antonov
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-15 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-15 (2019)
Although the tricyclic antidepressant amitriptyline (ATL) is widely used in the clinic, the mechanism underlying its high therapeutic efficacy against neuropathic pain remains unclear. NMDA receptors (NMDARs) represent a target for ATL and are involv
Autor:
Nina P. Vanchakova, Daria A. Belinskaia, Oleg I. Barygin, Natalia N. Shestakova, Mariia A. Belinskaia
Publikováno v:
Pharmaceuticals, Vol 12, Iss 2, p 99 (2019)
Pharmaceuticals
Pharmaceuticals
Clinical observations have shown that patients with chronic neuropathic pain or itch exhibit symptoms of increased anxiety, depression and cognitive impairment. Such patients need corrective therapy with antidepressants, antipsychotics or anticonvuls
Autor:
Nina Pavlovna Vanchakova, Yu. D. Stepanenko, Sergei M. Antonov, Natalia N. Shestakova, D. A. Sibarov, S. I. Boykov, D. A. Belinskaya
Publikováno v:
Журнал эволюционной биохимии и физиологии. 56:797-797